231 related articles for article (PubMed ID: 30552836)
1. Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features.
Moneta GM; Pires Marafon D; Marasco E; Rosina S; Verardo M; Fiorillo C; Minetti C; Bracci-Laudiero L; Ravelli A; De Benedetti F; Nicolai R
Arthritis Rheumatol; 2019 Jun; 71(6):1011-1021. PubMed ID: 30552836
[TBL] [Abstract][Full Text] [Related]
2. Myogenic Progenitor Cells Exhibit Type I Interferon-Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis.
Gitiaux C; Latroche C; Weiss-Gayet M; Rodero MP; Duffy D; Bader-Meunier B; Glorion C; Nusbaum P; Bodemer C; Mouchiroud G; Chelly J; Germain S; Desguerre I; Chazaud B
Arthritis Rheumatol; 2018 Jan; 70(1):134-145. PubMed ID: 28941175
[TBL] [Abstract][Full Text] [Related]
3. Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.
Shrestha S; Wershil B; Sarwark JF; Niewold TB; Philipp T; Pachman LM
Arthritis Rheum; 2010 Sep; 62(9):2813-22. PubMed ID: 20506305
[TBL] [Abstract][Full Text] [Related]
4. From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies.
Hou C; Durrleman C; Periou B; Barnerias C; Bodemer C; Desguerre I; Quartier P; Melki I; Rice GI; Rodero MP; Charuel JL; Relaix F; Bader-Meunier B; Authier F; Gitiaux C
Arthritis Rheumatol; 2021 Jun; 73(6):1044-1052. PubMed ID: 33314705
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
Bilgic H; Ytterberg SR; Amin S; McNallan KT; Wilson JC; Koeuth T; Ellingson S; Newman B; Bauer JW; Peterson EJ; Baechler EC; Reed AM
Arthritis Rheum; 2009 Nov; 60(11):3436-46. PubMed ID: 19877033
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126.
Kim E; Cook-Mills J; Morgan G; Sredni ST; Pachman LM
Arthritis Rheum; 2012 Nov; 64(11):3809-17. PubMed ID: 22740338
[TBL] [Abstract][Full Text] [Related]
7. Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy.
Fall N; Bove KE; Stringer K; Lovell DJ; Brunner HI; Weiss J; Higgins GC; Bowyer SL; Graham TB; Thornton S; Grom AA
Arthritis Rheum; 2005 Oct; 52(10):3175-80. PubMed ID: 16200621
[TBL] [Abstract][Full Text] [Related]
8. MHC class I and II expression in juvenile dermatomyositis skeletal muscle.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Sachetti S; Lotufo S; Matsumura N; Marie SK
Clin Exp Rheumatol; 2009; 27(3):519-26. PubMed ID: 19604449
[TBL] [Abstract][Full Text] [Related]
9. Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy.
Salajegheh M; Kong SW; Pinkus JL; Walsh RJ; Liao A; Nazareno R; Amato AA; Krastins B; Morehouse C; Higgs BW; Jallal B; Yao Y; Sarracino DA; Parker KC; Greenberg SA
Ann Neurol; 2010 Jan; 67(1):53-63. PubMed ID: 20186858
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis.
Tezak Z; Hoffman EP; Lutz JL; Fedczyna TO; Stephan D; Bremer EG; Krasnoselska-Riz I; Kumar A; Pachman LM
J Immunol; 2002 Apr; 168(8):4154-63. PubMed ID: 11937576
[TBL] [Abstract][Full Text] [Related]
11. Gene Expression Profiling in Blood and Affected Muscle Tissues Reveals Differential Activation Pathways in Patients with New-onset Juvenile and Adult Dermatomyositis.
López De Padilla CM; Crowson CS; Hein MS; Pendegraft RS; Strausbauch MA; Niewold TB; Ernste FC; Peterson E; Baechler EC; Reed AM
J Rheumatol; 2017 Jan; 44(1):117-124. PubMed ID: 27803134
[TBL] [Abstract][Full Text] [Related]
12. Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsy samples from patients with untreated juvenile dermatomyositis suggest self-renewal capacity.
Wang M; Xie H; Shrestha S; Sredni S; Morgan GA; Pachman LM
Arthritis Rheum; 2012 Oct; 64(10):3478-85. PubMed ID: 22674142
[TBL] [Abstract][Full Text] [Related]
13. Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis.
Shinjo SK; Sallum AM; Silva CA; Marie SK
Clinics (Sao Paulo); 2012 Aug; 67(8):885-90. PubMed ID: 22948454
[TBL] [Abstract][Full Text] [Related]
14. The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis.
Lu X; Tang Q; Lindh M; Dastmalchi M; Alexanderson H; Popovic Silwerfeldt K; Agerberth B; Lundberg IE; Wick C
J Autoimmun; 2017 Mar; 78():46-56. PubMed ID: 28012697
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.
Preuße C; Allenbach Y; Hoffmann O; Goebel HH; Pehl D; Radke J; Doeser A; Schneider U; Alten RH; Kallinich T; Benveniste O; von Moers A; Schoser B; Schara U; Stenzel W
Acta Neuropathol Commun; 2016 Apr; 4(1):45. PubMed ID: 27121733
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis.
De Luna N; Suárez-Calvet X; Lleixà C; Diaz-Manera J; Olivé M; Illa I; Gallardo E
Sci Rep; 2017 Aug; 7(1):8595. PubMed ID: 28819164
[TBL] [Abstract][Full Text] [Related]
17. Distinct interferon signatures stratify inflammatory and dysimmune myopathies.
Rigolet M; Hou C; Baba Amer Y; Aouizerate J; Periou B; Gherardi RK; Lafuste P; Authier FJ
RMD Open; 2019; 5(1):e000811. PubMed ID: 30886734
[TBL] [Abstract][Full Text] [Related]
18. Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis.
Gallardo E; de Andrés I; Illa I
J Neuropathol Exp Neurol; 2001 Sep; 60(9):847-55. PubMed ID: 11556541
[TBL] [Abstract][Full Text] [Related]
19. Interferon β is associated with type 1 interferon-inducible gene expression in dermatomyositis.
Liao AP; Salajegheh M; Nazareno R; Kagan JC; Jubin RG; Greenberg SA
Ann Rheum Dis; 2011 May; 70(5):831-6. PubMed ID: 21177291
[TBL] [Abstract][Full Text] [Related]
20. Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis.
Huard C; Gullà SV; Bennett DV; Coyle AJ; Vleugels RA; Greenberg SA
Br J Dermatol; 2017 May; 176(5):1224-1230. PubMed ID: 27564228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
